Trial Profile
An observational study investigating efficacy and safety of the combination of rilpivirine and dolutegravir in patients with HIV-1 infection in clinical practice
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Dec 2016
Price :
$35
*
At a glance
- Drugs Dolutegravir (Primary) ; Rilpivirine (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions; Therapeutic Use
- 30 Dec 2016 New trial record